According To FDA Report, J&J Plant Still Has Quality Control Issues

According to a Daily Finance news story released yesterday, regulators revealed that Johnson & Johnson “still hasn't solved all the problems at the Pennsylvania plant largely responsible for a huge recall of children's medicine earlier this year.” Read more

0 1226

“Significant Violations” Still Found By FDA At Johnson & Johnson Manufacturing Plant

The Wall Street Journal reports that the U.S. Food and Drug Administration again cited the pharmaceutical manufacturer, Johnson & Johnson. This time, the FDA found that during an inspection of a Puerto Rico manufacturing plant, the drug maker had “various... Read more

0 1207

Depuy ASR Hip Recall Symptomatic of Deeper Issues

The August 2010 voluntary Depuy ASR Recall and subsequent Depuy Hip Class Action Lawsuit cases have revealed more problems than patients might suspect. Johnson & Johnson seems to be facing a never ending onslaught of product recalls, factory closures, lawsuits,... Read more

Johnson & Johnson

$26,000,000

$25,900,000

$25,000,000